Primary data analysis on the use of antidementia drugs in German patients with Alzheimer’s disease across all severity stages of the disease

Authors :: Heßmann, P
Dodel, R
Kis, B
Zeidler, J
Klora, M
Reese, JP
Balzer-Geldsetzer, M
Source :: 16. Deutscher Kongress für Versorgungsforschung (DKVF); 20171004-20171006; Berlin; DOCP164 /20170926/
Publication Year :: 2017
Publisher :: German Medical Science GMS Publishing House, 2017.
Abstract: Background: Alzheimer’s disease (AD) is one of the most common neurodegenerative diseases in the elderly with more than 600.000 patients in Germany. Curative therapies for AD are lacking. Earlier studies showed positive effects of antidementia drugs (ADDs) on the patients’ cognition, the[for full text, please go to the a.m. URL]<br />16. Deutscher Kongress für Versorgungsforschung (DKVF)

Language :: English
Database :: OpenAIRE
Journal :: 16. Deutscher Kongress für Versorgungsforschung (DKVF); 20171004-20171006; Berlin; DOCP164 /20170926/
Accession number :: edsair.doi.dedup.....1bf27b05df125bd9e7504fc5ad18e049
Full Text :: https://doi.org/10.3205/17dkvf397

Full Text Access

Tools